Announce Date | 08/06/2025 |
EPS Normalized Actual | $0.53 (Beat by $0.11) |
EPS GAAP Actual | $0.53 (Beat by $0.11) |
Revenue Actual | $1.12037B |
Revenue Surprise | Beat by $1120.37M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.55273 |
EPS GAAP Estimate | $1.55273 |
Revenue Estimate | $1.367920281B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.78 | 16.4 | 4.313 | 5.01506 | 1 |
Dec 2028 | 5.24 | 14.96 | 4.92493 | 5.55822 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.18 | -0.69029 | 1.12037B | -5.52% | 88.22M |
FQ1 2025 (Mar 2025) | 1.58 | 0.26794 | 1.2965B | -21.94% | 214.38M |
FQ4 2024 (Dec 2024) | 1.29 | 1.08782 | 1.27014B | -7.67% | 117.91M |
FQ3 2024 (Sep 2024) | 0.037 | 0.037 | 1.07918B | -8.37% | 1079.18M |
FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 1.18217B | -9.43% | 1182.17M |
FQ1 2024 (Mar 2024) | 1.22 | 1.22 | 1.58096B | -1.41% | 1580.96M |
FQ4 2023 (Dec 2023) | 1.01 | 1.01 | 1.36753B | -3.9% | 1367.53M |
FQ3 2023 (Sep 2023) | 0.0451 | 0.0451 | 1.16949B | 100% | 1169.49M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
1.55273
Consensus Revenue Estimates
1.367920281B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.73 | -- | 1.64601 | 1.83115 | 1 |
FQ3 2027 (Sep 2027) | -0.29 | -- | -0.31478 | -0.25378 | 2 |
FQ2 2027 (Jun 2027) | 0.47 | -- | 0.4113 | 0.51016 | 2 |
FQ1 2027 (Mar 2027) | 2.52 | -- | 2.39766 | 2.66734 | 1 |
FQ4 2026 (Dec 2026) | 1.6 | -- | 1.52232 | 1.69355 | 1 |
FQ3 2026 (Sep 2026) | 0.17 | -- | 0.17 | 0.17 | 1 |
FQ2 2026 (Jun 2026) | 0.49 | 136.73 | 0.49 | 0.49 | 1 |
FQ1 2026 (Mar 2026) | 1.77 | 10.73 | 1.77 | 1.77 | 1 |
FQ4 2025 (Dec 2025) | 1.55273 | 16.92 | 1.47735 | 1.64351 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5B | -- | 1.45B | 1.57B | 1 |
FQ3 2027 (Sep 2027) | 1.74B | -- | 1.57B | 1.85B | 2 |
FQ2 2027 (Jun 2027) | 1.69B | -- | 1.53B | 1.8B | 2 |
FQ1 2027 (Mar 2027) | 1.38B | -- | 1.33B | 1.44B | 1 |
FQ4 2026 (Dec 2026) | 1.34B | -- | 1.29B | 1.4B | 1 |
FQ3 2026 (Sep 2026) | 1.56B | -- | 1.56B | 1.56B | 1 |
FQ2 2026 (Jun 2026) | 1.52B | 26.07 | 1.52B | 1.52B | 1 |
FQ1 2026 (Mar 2026) | 1.47B | 11.89 | 1.47B | 1.47B | 1 |
FQ4 2025 (Dec 2025) | 1.37B | 7.15 | 1.32B | 1.43B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.51029 | -0.18 | -0.69029 | 383.49% |
FQ1 2025 (Mar 2025) | 1.31206 | 1.58 | 0.26794 | 16.96% |
FQ4 2024 (Dec 2024) | 0.20218 | 1.29 | 1.08782 | 84.33% |
FQ3 2024 (Sep 2024) | 0.037 | 0.037 | 100% | |
FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 100% | |
FQ1 2024 (Mar 2024) | 1.22 | 1.22 | 100% | |
FQ4 2023 (Dec 2023) | 1.01 | 1.01 | 100% | |
FQ3 2023 (Sep 2023) | 0.0451 | 0.0451 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.03B | $1.12B | $88.22M | 7.87% |
FQ1 2025 (Mar 2025) | $1.08B | $1.3B | $214.38M | 16.54% |
FQ4 2024 (Dec 2024) | $1.15B | $1.27B | $117.91M | 9.28% |
FQ3 2024 (Sep 2024) | $0B | $1.08B | $1079.18M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.18B | $1182.17M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.58B | $1580.96M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.37B | $1367.53M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.17B | $1169.49M | 100% |